Peter Múdrý

1.3k total citations
36 papers, 674 citations indexed

About

Peter Múdrý is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Peter Múdrý has authored 36 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Peter Múdrý's work include Sarcoma Diagnosis and Treatment (19 papers), Tumors and Oncological Cases (6 papers) and Antifungal resistance and susceptibility (5 papers). Peter Múdrý is often cited by papers focused on Sarcoma Diagnosis and Treatment (19 papers), Tumors and Oncological Cases (6 papers) and Antifungal resistance and susceptibility (5 papers). Peter Múdrý collaborates with scholars based in Czechia, France and Netherlands. Peter Múdrý's co-authors include Jaroslav Štěrba, Gianni Bisogno, Andrea Ferrari, Daniel Orbach, Gian Luca De Salvo, Anna Kelsey, Soledad Gallego, Michela Casanova, Johannes H. M. Merks and Meriel Jenney and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Peter Múdrý

31 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Múdrý Czechia 13 393 245 184 176 110 36 674
Toshiaki Kamei Japan 18 528 1.3× 136 0.6× 101 0.5× 138 0.8× 79 0.7× 96 912
Valentina Fausti Italy 16 260 0.7× 321 1.3× 99 0.5× 79 0.4× 74 0.7× 46 681
Aydanur Kargı Türkiye 14 211 0.5× 208 0.8× 131 0.7× 119 0.7× 132 1.2× 60 649
Giada Maria Vecchio Italy 18 199 0.5× 135 0.6× 184 1.0× 140 0.8× 106 1.0× 51 729
İnci̇ Ayan Türkiye 15 285 0.7× 250 1.0× 102 0.6× 97 0.6× 250 2.3× 44 708
Chik Hong Kuick Singapore 14 175 0.4× 105 0.4× 117 0.6× 101 0.6× 48 0.4× 50 473
Marina Perelman Israel 18 372 0.9× 229 0.9× 354 1.9× 64 0.4× 196 1.8× 40 985
Christine Müller Germany 5 344 0.9× 148 0.6× 84 0.5× 77 0.4× 123 1.1× 9 523
Lothar Krause Germany 18 154 0.4× 260 1.1× 113 0.6× 250 1.4× 47 0.4× 61 1.1k
Aaron Auerbach United States 14 195 0.5× 204 0.8× 62 0.3× 183 1.0× 121 1.1× 45 671

Countries citing papers authored by Peter Múdrý

Since Specialization
Citations

This map shows the geographic impact of Peter Múdrý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Múdrý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Múdrý more than expected).

Fields of papers citing papers by Peter Múdrý

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Múdrý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Múdrý. The network helps show where Peter Múdrý may publish in the future.

Co-authorship network of co-authors of Peter Múdrý

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Múdrý. A scholar is included among the top collaborators of Peter Múdrý based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Múdrý. Peter Múdrý is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mandeville, Henry, Gianni Bisogno, Véronique Minard‐Colin, et al.. (2024). Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trial. Cancer. 130(23). 4071–4084. 3 indexed citations
2.
Apostolopoulos, Vasileios, et al.. (2024). Osteosarcomas of the hand and foot: A sarcoma‑center case series experience. Oncology Letters. 29(1). 54–54.
3.
Bisogno, Gianni, Véronique Minard‐Colin, Ilaria Zanetti, et al.. (2023). Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study. Journal of Clinical Oncology. 41(13). 2342–2349. 21 indexed citations
4.
Apostolopoulos, Vasileios, et al.. (2023). Proximal Tibia Tumour Location and Curettage Are Major Risk Factors of Local Recurrence in Giant Cell Tumour of Bone. Cancers. 15(18). 4664–4664. 1 indexed citations
5.
Pokorná, Petra, Giannoula Klement, Veronika Kanderová, et al.. (2022). Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing. JCO Precision Oncology. 6(6). e2100525–e2100525. 2 indexed citations
6.
Bisogno, Gianni, Véronique Minard‐Colin, Julia Daragjati, et al.. (2021). Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group. Pediatric Blood & Cancer. 69(2). e29376–e29376. 5 indexed citations
7.
Múdrý, Peter, et al.. (2021). Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis. Journal of bone oncology. 28. 100362–100362. 20 indexed citations
8.
Bisogno, Gianni, Gian Luca De Salvo, Christophe Bergeron, et al.. (2019). Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology. 20(11). 1566–1575. 149 indexed citations
9.
Dubská, Lenka Zdražilová, Peter Múdrý, Pavel Mazánek, et al.. (2017). Immunomonitoring of patients treated with personalized dendritic cell-based vaccine. Annals of Oncology. 28. xi17–xi17. 2 indexed citations
10.
Hermanová, Markéta, et al.. (2017). Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma. Biomedical Papers. 162(1). 54–60. 10 indexed citations
11.
Orbach, Daniel, Bernadette Brennan, Angela De Paoli, et al.. (2016). Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience. European Journal of Cancer. 57. 1–9. 81 indexed citations
12.
13.
Škoda, J., Tomáš Loja, Iva Staniczková Zambo, et al.. (2016). Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice. Tumor Biology. 37(7). 9535–9548. 29 indexed citations
14.
André, Nicolás, Michal Kýr, Viera Bajčiová, et al.. (2012). Metronomic Chemotherapy with the COMBAT Regimen in Advanced Pediatric Malignancies: A Multicenter Experience. Oncology. 82(5). 249–260. 56 indexed citations
15.
Múdrý, Peter, et al.. (2011). Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination. Archives of Disease in Childhood. 96(5). 476–477. 38 indexed citations
16.
Krsková, Lenka, et al.. (2011). Rhabdomyosarcoma: Molecular analysis of Igf2, MyoD1 and Myogenin expression.. Neoplasma. 58(5). 415–423. 6 indexed citations
17.
Křenová, Zdenka, et al.. (2010). Successful Treatment of Life-threatening Candida Peritonitis in a Child With Abdominal Non-Hodgkin Lymphoma Using Efungumab and Amphotericin B Colloid Dispersion. Journal of Pediatric Hematology/Oncology. 32(2). 128–130. 10 indexed citations
18.
Krsková, Lenka, et al.. (2010). Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 456(5). 463–472. 14 indexed citations
19.
Kepák, Tomáš, Marek Blatný, Martin Jelínek, et al.. (2008). Následky léčby dětských nádorových onemocnění v oblasti neurokognitivních funkcí a jejich vliv na kvalitu života.. Pediatrie pro praxi. 8(6). 353–357. 1 indexed citations
20.
Štěrba, Jaroslav, et al.. (2005). SUCCESSFUL TREATMENT OF ASPERGILLUS BRAIN ABSCESS IN A CHILD WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND LIVER FAILURE. Pediatric Hematology and Oncology. 22(8). 649–655. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiaki Kamei Breakdown of academic impact, for papers by Valentina Fausti Breakdown of academic impact, for papers by Aydanur Kargı Breakdown of academic impact, for papers by Giada Maria Vecchio Breakdown of academic impact, for papers by İnci̇ Ayan Breakdown of academic impact, for papers by Chik Hong Kuick Breakdown of academic impact, for papers by Marina Perelman Breakdown of academic impact, for papers by Christine Müller Breakdown of academic impact, for papers by Lothar Krause Breakdown of academic impact, for papers by Aaron Auerbach
Rankless by CCL
2026